(Media Alert: 7 July 2026): Future Health – A Global Initiative by Abu Dhabi announced that it has joined the BioConvergence Cancer Alliance as a Founding Member. Established by the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology (MIT), the Alliance brings together leading organisations committed together with academia to accelerate progress in cancer care, research and innovation.
The announcement, which took place on the sidelines of BIO International Convention 2026 in San Diego, marks a significant step in strengthening collaboration between the world’s leading cancer research institutions and Future Health’s ecosystem.
Increasingly, progress against complex diseases such as cancer is being driven through collaborations with healthcare and government organisations, researchers, innovators, and industry partners joining forces to share expertise, accelerate scientific discovery, and translate research into actionable real-world impact.
While cancer remains a leading cause of deaths worldwide, approximately 38% of cancers can currently be prevented by avoiding risk factors and implementing existing evidence-based prevention strategies, with additional lives saved through early detection.
As a Founding Member of the Alliance, Future Health will support efforts to strengthen international collaboration and foster growth in areas including cancer research, precision medicine, artificial intelligence, and next-generation healthcare technologies.
The collaboration reflects growing recognition that tackling cancer requires greater cross-sector work to accelerate innovation and improve patient outcomes. Future Health – A Global Initiative by Abu Dhabi is a platform for global collaboration that convenes stakeholders across policy, research, investment and industry to accelerate collaboration, advance innovation and shape the future of health systems.
The collaboration also highlights the increasing role the Middle East region plays in advancing global healthcare innovation, with Abu Dhabi continuing to invest in research, life sciences and partnerships that are designed to support the development of future-ready health systems.